PEG Ratio

The PEG ratio combines the price-to-earnings (P/E) multiple with the company's expected earnings growth rate, helping investors judge whether a stock's price is fair relative to its projected growth.

A ratio of 1.40x means the stock is trading at 1.4 times its expected profit growth, which is above the healthcare sector median of 0.77x, placing CPRX in the 59th percentile among its peers — slightly higher than typical. However, there is no trend data: the year-over-year and quarter-over-quarter changes are both listed as N/A, and the only available value is the current 1.40x, so no historical trajectory can be assessed. The elevated level relative to the sector median suggests the stock may be priced at a premium for its expected growth, but without any trend direction, it is impossible to gauge whether that premium is widening or narrowing. This lack of trend information limits the risk or opportunity signals; investors cannot infer momentum or valuation compression. Given the neutral verdict on CPRX, this metric generally aligns — the PEG is not extreme enough to strongly call the stock overvalued or undervalued, and the absence of trend data provides no clear push in either direction, supporting a neutral stance.

Frequently Asked Questions

Closest Sector Peers